🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

J. Kellogg Parsons

University of Michigan

ORCID: 0000-0002-3676-9730
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease”.

Testosterone therapy does not increase the risks of prostate cancer recurrence or death after definitive treatment for localized disease

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0241-3
N/A
0DataRank · unranked
14 citations

Sunil Patel, J. Kellogg Parsons, Rishi Deka, Abhishek Kumar, John Einck +8 more

A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-19-1527
N/A
0DataRank · unranked
39 citations

Chun Chieh Fan, Roshan Karunamuni, Eleanor Walsh, Emma L. Turner, J. Athene Lane +57 more

Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.9452
N/A
0DataRank · unranked
12 citations

Juan Javier‐Desloges, Rishi Deka, P.T. Courtney, Vinit Nalawade, Loren K. Mell +4 more

Active surveillance for intermediate‐risk prostate cancer in African American and non‐Hispanic White men

Cancer(2021)10.1002/cncr.33824
N/A
0DataRank · unranked
8 citations

Rishi Deka, Nikhil V. Kotha, Daniel Cherry, Mia Salans, Tyler J. Nelson +9 more

Impact of age on treatment response in men with prostate cancer treated with radiotherapy

BJUI Compass(2021)10.1002/bco2.132
N/A
0DataRank · unranked
5 citations

Tyler J. Nelson, Rana R. McKay, A. Karim Kader, J. Kellogg Parsons, John Einck +6 more

Association of increased intensity of prostate-specific antigen screening in younger African American men with improved prostate cancer outcomes.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5004
N/A
0DataRank · unranked
0 citations

Nikhil V. Kotha, Vinit Nalawade, Alexander S. Qian, Rohith S. Voora, Tyler J. Nelson +4 more

Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance

Journal of the National Comprehensive Cancer Network(2022)10.6004/jnccn.2021.7065
N/A
0DataRank · unranked
28 citations

Rishi Deka, Nikhil V. Kotha, Daniel Cherry, Mia Salans, Tyler J. Nelson +9 more

Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men’s Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance])

European Urology Focus(2022)10.1016/j.euf.2022.03.007
N/A
0DataRank · unranked
3 citations

David Zahrieh, Devin Patel, James L. Mohler, Ronald C. Chen, Electra D. Paskett +12 more

Immunotherapy to prevent progression on active surveillance study (IPASS): A phase II, randomized, double-blind, controlled trial of PROSTVAC in prostate cancer patients who are candidates for active surveillance.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.249
N/A
0DataRank · unranked
2 citations

Peter A. Pinto, Howard L. Parnes, Christian P. Pavlovich, Edward Uchio, Mike Nguyen +13 more